stockrow
Friday 6 November 2026
Export DBD’s income statement to Excel — free account
Diebold Nixdorf, Incorporated
DBD Technology Software Application
Diebold Nixdorf, Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $3.8 billion, up 1.46% from fiscal 2024.
- Revenue
- +5.19%
- EPS
- −81.4%
- Free cash flow
- −346.1%
- Total debt
- +1.64%
Quarter to September 2026, against a year earlier
58.30
0.32
+0.55%
Follow DBD
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
7 | 7 | 7 | 7 |
+8 more TTM periods Free account |
| 7.46% | 10.68% | 10.70% | 9.26% | ||
| 2.08% | 2.97% | 2.89% | 2.56% | ||
ROIC |
7.73% | 9.40% | 9.62% | 9.30% | |
Return on Tangible Assets |
11.52% | 16.66% | 15.66% | 13.49% | |
Average Days of Receivables |
63.31 | 61.48 | 56.50 | 64.14 | |
Free Cash Flow per Share |
3.77 | 6.16 | 7.23 | 6.49 | |
Free Cash Flow |
127.20 | 212.00 | 253.60 | 239.00 | |
Capital Expenditures |
(61.00) | (61.00) | (63.10) | (61.70) | |
| Other line items | |||||
Cash ROIC |
6.12% | 9.63% | 10.84% | 9.72% | |
Accounts Receivable Turnover |
6.22 | 6.19 | 6.43 | 6.05 | |
Accounts Payable Turnover |
6.16 | 6.17 | 6.19 | 6.38 | |
Inventory Turnover |
5.07 | 4.95 | 5.22 | 5.42 | |
Average Days of Payables |
61.17 | 63.83 | 61.07 | 55.32 | |
Days of Inventory on Hand |
69.70 | 75.14 | 69.99 | 66.85 | |
Tax Rate |
(0.33) | (0.28) | (0.22) | (0.19) | |
Research and Development Expense of Revenue |
2.13% | 2.17% | 2.23% | 2.28% | |
Selling, General and Administrative Expense of Revenue |
17.02% | 16.68% | 16.54% | 16.62% | |
Share Based Compensation of Revenue |
0.37% | 0.34% | 0.32% | 0.32% | |
Interest Coverage |
2.23 | 2.74 | 2.80 | 2.82 | |
Operating CF/Net income |
2.45 | 2.46 | 2.94 | 3.18 | |
Depreciation/Fixed assets |
0.42 | 0.43 | 0.45 | 0.47 | |
Capex/Depreciation |
(0.46) | (0.46) | (0.48) | (0.46) | |
Revenue per Share |
116.35 | 112.56 | 109.87 | 103.42 | |
Operating CF per Share |
5.58 | 7.94 | 9.02 | 8.17 | |
Capex per Share |
(1.81) | (1.77) | (1.80) | (1.68) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 |
Columns are period end dates · fundamentals updated 2 Nov 2026